ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.325
0.06%
Bitcoin
66,677.86
0.74%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Medicis Pharmaceutical Corp. (MRX)

  7. Medicis Pharmaceutical Corp. (MRX) Noticias

MRX

Medicis (MRX)

Medicis Pharmaceutical Corp.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:MRX
FechaHoraFuenteTítuloSímboloCompañía
10/12/201205:02Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MRXMedicis Pharmaceutical Corp.
10/12/201205:02Edgar (US Regulatory)Current report filing (8-K)NYSE:MRXMedicis Pharmaceutical Corp.
06/12/201207:15ZacksVRX and Gladerma Ink Revised Deal - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
05/12/201217:51PR Newswire (US)Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400NYSE:MRXMedicis Pharmaceutical Corp.
05/12/201215:31PR Newswire (Canada)Valeant Pharmaceuticals And Galderma Agree On Revised Agreement TermsNYSE:MRXMedicis Pharmaceutical Corp.
28/11/201215:21Edgar (US Regulatory)Annual Report (management Company) (nsar-b)NYSE:MRXMedicis Pharmaceutical Corp.
28/11/201215:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:MRXMedicis Pharmaceutical Corp.
28/11/201215:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:MRXMedicis Pharmaceutical Corp.
28/11/201207:00MarketwiredAnalyst Opinion on Mylan and Medicis Pharmaceutical - Acquisitions and Approvals Abound in Generic Drug IndustryNYSE:MRXMedicis Pharmaceutical Corp.
28/11/201207:00PR Newswire (US)Valeant Pharmaceuticals Announces New Management AppointmentsNYSE:MRXMedicis Pharmaceutical Corp.
27/11/201218:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MRXMedicis Pharmaceutical Corp.
20/11/201207:45ZacksValeant a Step Closer to Medicis - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
19/11/201211:14ZacksAllergan to Buy SkinMedica - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
16/11/201206:51PR Newswire (US)Valeant Pharmaceuticals Receives FTC Clearance For Medicis AcquisitionNYSE:MRXMedicis Pharmaceutical Corp.
14/11/201217:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MRXMedicis Pharmaceutical Corp.
12/11/201211:03ZacksGlitch in Medicis-Valeant Deal - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
09/11/201214:18Dow Jones NewsMedicis Pharma Shares Fall on Q-Med LawsuitNYSE:MRXMedicis Pharmaceutical Corp.
09/11/201205:03Edgar (US Regulatory)Quarterly Report (10-Q)NYSE:MRXMedicis Pharmaceutical Corp.
09/11/201205:03Edgar (US Regulatory)Quarterly Report (10-q)NYSE:MRXMedicis Pharmaceutical Corp.
05/11/201208:31ZacksValeant Beats on All Fronts - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
05/11/201205:10Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NYSE:MRXMedicis Pharmaceutical Corp.
05/11/201205:10Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NYSE:MRXMedicis Pharmaceutical Corp.
15/10/201211:35ZacksMedicis, Revance Settle Litigation - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
26/09/201211:25ZacksValeant Buys QLT's Visudyne - Analyst BlogNYSE:MRXMedicis Pharmaceutical Corp.
21/09/201207:00GlobeNewswire Inc.Medicis Declares Cash DividendNYSE:MRXMedicis Pharmaceutical Corp.
18/09/201205:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NYSE:MRXMedicis Pharmaceutical Corp.
15/09/201212:55Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Medicis Pharmaceutical CorporationNYSE:MRXMedicis Pharmaceutical Corp.
14/09/201218:00Business WireFaruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)NYSE:MRXMedicis Pharmaceutical Corp.
14/09/201208:22Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNYSE:MRXMedicis Pharmaceutical Corp.
14/09/201207:00PR Newswire (US)Valeant Pharmaceuticals To Syndicate Incremental LoansNYSE:MRXMedicis Pharmaceutical Corp.
 Showing the most relevant articles for your search:NYSE:MRX

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
FX
EURMXN
Euro vs MXN
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados